ICRM
NPSP

Insight Capital Research & Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Insight Capital Research & Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-258,274
Closed -$7.43M – 186
2013
Q3 		$7.43M Buy
+258,274
New +$5.93M 1.8% 13

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Insight Capital Research & Management's NPSP Position: Q4 2013 in Review

Insight Capital Research & Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2013, closing a stake of 258,274 shares — an estimated $7.43M sold.

Insight Capital Research & Management first reported a position in NPSP in Q3 2013 and held it in 1 quarter. The position peaked at $7.43M in Q3 2013. 191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

  • Insight Capital Research & Management reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Insight Capital Research & Management sold 258,274 NPS PHARMACEUTICALS INC shares in Q4 2013, an estimated $7.43M.
  • Insight Capital Research & Management first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Insight Capital Research & Management's NPS PHARMACEUTICALS INC position peaked at $7.43M in Q3 2013.
  • 191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on Insight Capital Research & Management's 13F filing for Q4 2013, filed 12 Feb 2014.